Tectonic Therapeutic TECX
NASDAQ TECX
$23.34 -0.17 (-0.72%)
At close: Sep 29, 2026 · 4:00 PM EDT

Tectonic Therapeutic (TECX) Non-Current Debt (2021 - 2023)

Updated

Tectonic Therapeutic (TECX) posted Non-Current Debt of $15.36 million for Q1 2023, up 2.2% from $15.02 million a year earlier and up 0.5% from the prior quarter.

Analysis

Tectonic Therapeutic (TECX) Non-Current Debt (2021 - 2023) Analysis & Trends

At the end of FY2022, Tectonic Therapeutic's Non-Current Debt came in at $15.28 million, up 2.2% from FY2021.

  • In prior years, Tectonic Therapeutic's Non-Current Debt was $14.95 million in FY2021.
  • According to Business Quant data, Non-Current Debt for the three prior quarters was $15.28 million (Q4 2022), $15.21 million (Q3 2022) and $15.1 million (Q2 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 37.34 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 62.48 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 51.08 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -108.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 51.86 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 23.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 60.50 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Tectonic Therapeutic 452.22 Mn 452.22 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 15.36 Mn
Dec 31, 2022 15.28 Mn
Sep 30, 2022 15.21 Mn
Jun 30, 2022 15.10 Mn
Mar 31, 2022 15.02 Mn
Dec 31, 2021 14.95 Mn
API Access

Tectonic Therapeutic Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=TECX&period=max&api_key=YOUR_API_KEY